NCT00964236
Phenylketonuria
The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.
The objective of the study is to determine whether Kuvan™ (sapropterin) improves the strength of the functional connectivity between brain regions in individuals with PKU.
All
From 6 Years
Yes
Sapropterin
Observational
20
2009-08
2018-01-04
Columbia, Missouri, United States
*required fields
"*" indicates required fields